Shanghai Pharmaceuticals Unit's Methylcobalamin Tablets Passes Drug Regulator's Evaluation

MT Newswires Live08-06

Shanghai Pharmaceuticals Unit's Methylcobalamin Tablets Passes Drug Regulator's Evaluation The methylcobalamin tablets of Shanghai Pharmaceuticals Holding's (SHA:601607, HKG:2607) unit, Shanghai Xinya...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2457068609?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-06 12:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2457068609","market":"nz","top_or_hot":-1,"title":"Shanghai Pharmaceuticals Unit's Methylcobalamin Tablets Passes Drug Regulator's Evaluation","media":"MT Newswires Live","content":"<div>\n<p>Shanghai Pharmaceuticals Unit's Methylcobalamin Tablets Passes Drug Regulator's Evaluation The methylcobalamin tablets of Shanghai Pharmaceuticals Holding's (SHA:601607, HKG:2607) unit, Shanghai Xinya...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Pharmaceuticals Unit's Methylcobalamin Tablets Passes Drug Regulator's Evaluation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Pharmaceuticals Unit's Methylcobalamin Tablets Passes Drug Regulator's Evaluation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-06 12:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shanghai Pharmaceuticals Unit's Methylcobalamin Tablets Passes Drug Regulator's Evaluation The methylcobalamin tablets of Shanghai Pharmaceuticals Holding's (SHA:601607, HKG:2607) unit, Shanghai Xinya...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0099","symbol_name":"上海本地重组","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2457068609","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2457068609","pubTimestamp":1722919541,"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Shanghai Pharmaceuticals Unit's Methylcobalamin Tablets Passes Drug Regulator's Evaluation The methy","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"601607":"上海医药","BK0099":"上海本地重组","BK4526":"热门中概股","BK0188":"融资融券","BK4588":"碎股","BK0187":"一线龙头","02607":"上海医药","BK0175":"白马股","BK0184":"上海国资改革","NHLD":"National Holdings Corporation","BK0183":"MSCI概念","BK0209":"零售","BK0012":"证金概念","BK0196":"行业龙头","BK0097":"医药电商","BK0020":"浦东新区","BK4023":"应用软件","BK4585":"ETF&股票定投概念","HKD":"尚乘数科","BK0028":"国家队","BK1197":"保健护理产品经销商"},"translate_title":"上海医药单位甲钴胺片通过药监审评","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1,"NHLD":1,"HKD":1,"02607":0.9},"content_text":"Shanghai Pharmaceuticals Unit's Methylcobalamin Tablets Passes Drug Regulator's Evaluation The methylcobalamin tablets of Shanghai Pharmaceuticals Holding's (SHA:601607, HKG:2607) unit, Shanghai Xinya Pharmaceutical Minhang, passed the generic drug consistency evaluation of China's National Medical Products Administration, according to the company's filing on the Shanghai Stock Exchange.The pharmaceutical company spent 4 million yuan for the research and development, and the consistency evaluation of the drug, which is mainly used for peripheral neuropathy, the Tuesday filing noted.Shares of the company rose less than 2% on the Hong Kong bourse.Price (HKD): $18.87, Change: $-0.11, Percent Change: -0.58%","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2457068609"}